IL177444A0 - Analogs exhibiting inhibition of cell proliferation, methods of making, and uses thereof - Google Patents
Analogs exhibiting inhibition of cell proliferation, methods of making, and uses thereofInfo
- Publication number
- IL177444A0 IL177444A0 IL177444A IL17744406A IL177444A0 IL 177444 A0 IL177444 A0 IL 177444A0 IL 177444 A IL177444 A IL 177444A IL 17744406 A IL17744406 A IL 17744406A IL 177444 A0 IL177444 A0 IL 177444A0
- Authority
- IL
- Israel
- Prior art keywords
- making
- methods
- cell proliferation
- analogs exhibiting
- exhibiting inhibition
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/34—Oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/04—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/04—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D277/06—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Epoxy Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US54372404P | 2004-02-11 | 2004-02-11 | |
| US55580304P | 2004-03-24 | 2004-03-24 | |
| PCT/US2005/004759 WO2005086638A2 (en) | 2004-02-11 | 2005-02-11 | Analogs exhibiting inhibition of cell proliferation, methods of making, and uses thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL177444A0 true IL177444A0 (en) | 2006-12-10 |
Family
ID=34976061
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL177444A IL177444A0 (en) | 2004-02-11 | 2006-08-10 | Analogs exhibiting inhibition of cell proliferation, methods of making, and uses thereof |
Country Status (8)
| Country | Link |
|---|---|
| EP (1) | EP1723127A4 (en) |
| JP (1) | JP2007522247A (en) |
| AU (1) | AU2005220705A1 (en) |
| BR (1) | BRPI0507612A (en) |
| CA (1) | CA2559333A1 (en) |
| EA (1) | EA200601471A1 (en) |
| IL (1) | IL177444A0 (en) |
| WO (1) | WO2005086638A2 (en) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR101395146B1 (en) * | 2011-02-09 | 2014-05-16 | 부산대학교 산학협력단 | New compounds having skin whitening, antioxidant and PPAR activity, and medical use thereof |
| WO2014066613A2 (en) * | 2012-10-26 | 2014-05-01 | Zhejiang University | Sphingolipid metabolite mimetics |
| FI2968346T3 (en) * | 2013-03-15 | 2024-05-06 | Cancer Research Tech Llc | Methods and compositions for gamma-glutamyl cycle modulation |
| WO2023170024A1 (en) * | 2022-03-11 | 2023-09-14 | University Of Copenhagen | Camk2 modulators and their use in medicine |
| CN115894398B (en) * | 2022-12-02 | 2024-03-12 | 青岛科技大学 | Fluothiazole amide-containing insecticidal acaricide |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2058260T3 (en) * | 1987-03-24 | 1994-11-01 | Nippon Chemiphar Co | A PROCESS FOR THE PREPARATION OF A GLYCEROL DERIVATIVE. |
| US4826990A (en) * | 1987-09-30 | 1989-05-02 | American Home Products Corporation | 2-aryl substituted heterocyclic compounds as antiallergic and antiinflammatory agents |
| US5149704A (en) * | 1991-05-03 | 1992-09-22 | Abbott Laboratories | Platelet activating antagonists |
| FR2678938B1 (en) * | 1991-07-10 | 1993-10-08 | Rhone Poulenc Rorer Sa | PYRROLIDINE DERIVATIVES, THEIR PREPARATION AND THE MEDICINAL PRODUCTS CONTAINING THEM. |
| FR2700168B1 (en) * | 1993-01-07 | 1995-02-03 | Rhone Poulenc Rorer Sa | Thiazolidine derivatives, their preparation and the drugs containing them. |
| DE19546918A1 (en) * | 1995-12-15 | 1997-06-19 | Bayer Ag | Bicyclic heterocycles |
-
2005
- 2005-02-11 EA EA200601471A patent/EA200601471A1/en unknown
- 2005-02-11 AU AU2005220705A patent/AU2005220705A1/en not_active Abandoned
- 2005-02-11 CA CA002559333A patent/CA2559333A1/en not_active Abandoned
- 2005-02-11 WO PCT/US2005/004759 patent/WO2005086638A2/en active Search and Examination
- 2005-02-11 EP EP05749117A patent/EP1723127A4/en not_active Withdrawn
- 2005-02-11 BR BRPI0507612-9A patent/BRPI0507612A/en not_active IP Right Cessation
- 2005-02-11 JP JP2006553347A patent/JP2007522247A/en not_active Withdrawn
-
2006
- 2006-08-10 IL IL177444A patent/IL177444A0/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JP2007522247A (en) | 2007-08-09 |
| EP1723127A2 (en) | 2006-11-22 |
| CA2559333A1 (en) | 2005-09-22 |
| EP1723127A4 (en) | 2009-10-28 |
| WO2005086638A3 (en) | 2005-11-24 |
| WO2005086638A2 (en) | 2005-09-22 |
| AU2005220705A1 (en) | 2005-09-22 |
| BRPI0507612A (en) | 2007-07-03 |
| EA200601471A1 (en) | 2007-10-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP1962892A4 (en) | Inhibition of cell proliferation | |
| EP1756092A4 (en) | Novel inhibitors of rho-kinases | |
| GB2441530B (en) | Stem Cells | |
| IL177587A0 (en) | Batteries and methods of manufacture and uses thereof | |
| IL181587A0 (en) | Production of ??-abeta | |
| ZA200703069B (en) | Quinoxalines as B Raf inhibitors | |
| EP1788874A4 (en) | Salts of 5-azacytidine | |
| IL181305A0 (en) | Combinations for the treatment of diseases involving cell proliferation | |
| EP1743025A4 (en) | Methods for production of regulatory t cells and uses thereof | |
| EP1874731A4 (en) | Quinobenzoxazine analogs and methods of using thereof | |
| EP1863769A4 (en) | Hsp90 inhibitors, methods of making and uses therefor | |
| IL176942A0 (en) | Imidazolo-5-yl-2-anilinopyrimidines as agents for the inhibition of cell proliferation | |
| EP1743408A4 (en) | Cathodic lead insulator | |
| IS8570A (en) | Prostate-free stem cell proliferation | |
| EP1896605A4 (en) | Stimulation of pancreatic b cell proliferation | |
| ZA200703293B (en) | Cell bandage | |
| ZA200702157B (en) | Quinolone analogs as cell proliferation inhibitors | |
| IL177444A0 (en) | Analogs exhibiting inhibition of cell proliferation, methods of making, and uses thereof | |
| IL183136A0 (en) | Modified alginates, methods of production and use | |
| IL177647A0 (en) | Use of enzyme | |
| GB0426182D0 (en) | Photoporation of cells | |
| GB0412584D0 (en) | Composition of matter | |
| EP1809736A4 (en) | Cryopreservation of cells | |
| ZA200702789B (en) | High performance shaped articles,methods of making,and uses thereof | |
| GB2426180B (en) | Wristband |